157 related articles for article (PubMed ID: 36788310)
1. Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).
Versleijen-Jonkers YMH; Hillebrandt-Roeffen MHS; Weidema ME; Mooren J; von Rhein DT; de Bitter TJJ; Kroeze LI; Desar IME; Flucke UE
Sci Rep; 2023 Feb; 13(1):2653. PubMed ID: 36788310
[TBL] [Abstract][Full Text] [Related]
2. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
[TBL] [Abstract][Full Text] [Related]
4. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
[TBL] [Abstract][Full Text] [Related]
5. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract][Full Text] [Related]
6. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
[TBL] [Abstract][Full Text] [Related]
7. Reduced H3K27me3 expression in radiation-associated angiosarcoma of the breast.
Mentzel T; Kiss K
Virchows Arch; 2018 Mar; 472(3):361-368. PubMed ID: 28983701
[TBL] [Abstract][Full Text] [Related]
8. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
[TBL] [Abstract][Full Text] [Related]
9. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers.
Marchal C; Weber B; de Lafontan B; Resbeut M; Mignotte H; du Chatelard PP; Cutuli B; Reme-Saumon M; Broussier-Leroux A; Chaplain G; Lesaunier F; Dilhuydy JM; Lagrange JL
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):113-9. PubMed ID: 10219803
[TBL] [Abstract][Full Text] [Related]
10. Sporadic cutaneous angiosarcomas generally lack hypoxia-inducible factor 1alpha: a histologic and immunohistochemical study of 45 cases.
Abedalthagafi M; Rushing EJ; Auerbach A; Desouki MM; Marwaha J; Wang Z; Fanburg-Smith JC
Ann Diagn Pathol; 2010 Feb; 14(1):15-22. PubMed ID: 20123452
[TBL] [Abstract][Full Text] [Related]
11. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
[TBL] [Abstract][Full Text] [Related]
12. Optimal Clinical Management and the Molecular Biology of Angiosarcomas.
Chen TW; Burns J; Jones RL; Huang PH
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182685
[TBL] [Abstract][Full Text] [Related]
13. Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall.
Styring E; Fernebro J; Jönsson PE; Ehinger A; Engellau J; Rissler P; Rydholm A; Nilbert M; Vult von Steyern F
Breast Cancer Res Treat; 2010 Aug; 122(3):883-7. PubMed ID: 20087653
[TBL] [Abstract][Full Text] [Related]
14. CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas.
Venkataramani V; Küffer S; Cheung KCP; Jiang X; Trümper L; Wulf GG; Ströbel P
Clin Cancer Res; 2018 Jan; 24(2):460-473. PubMed ID: 29084920
[No Abstract] [Full Text] [Related]
15. Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features.
Ronchi A; Cozzolino I; Zito Marino F; De Chiara A; Argenziano G; Moscarella E; Pagliuca F; Franco R
Ann Diagn Pathol; 2020 Oct; 48():151597. PubMed ID: 32829071
[TBL] [Abstract][Full Text] [Related]
16. Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?
Azzariti A; Porcelli L; Mangia A; Saponaro C; Quatrale AE; Popescu OS; Strippoli S; Simone G; Paradiso A; Guida M
Exp Cell Res; 2014 Feb; 321(2):240-7. PubMed ID: 24384475
[TBL] [Abstract][Full Text] [Related]
17. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
[TBL] [Abstract][Full Text] [Related]
18. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
[TBL] [Abstract][Full Text] [Related]
19. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
[TBL] [Abstract][Full Text] [Related]
20. A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas.
Hadj-Hamou NS; Laé M; Almeida A; de la Grange P; Kirova Y; Sastre-Garau X; Malfoy B
Carcinogenesis; 2012 Jul; 33(7):1399-405. PubMed ID: 22532251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
